Key result
Higher cardiometabolic index linked to ~17% greater CHD prevalence per unit increase.
Why the study?
The association between the cardiometabolic index and coronary heart disease risk remained inadequately characterized in large populations.
Is the cardiometabolic index (CMI) associated with the prevalence of coronary heart disease in US adults?
Cross-Sectional (n=20,888)
Is the cardiometabolic index (CMI) associated with the prevalence of coronary heart disease in US adults?
The cardiometabolic index is independently and non-linearly associated with coronary heart disease risk, offering a practical tool for metabolic risk stratification.
Answers are grounded in this paper and cite their sources.
May support CMI for CHD risk assessment; cross-sectional data leave causality and clinical utility open.
BACKGROUND: The cardiometabolic index (CMI), a sex-specific marker combining lipid profiles with anthropometric measures, may reflect visceral adiposity dysfunction. Its association with coronary heart disease (CHD) risk remains inadequately characterized in large populations. METHODS: This cross-sectional study included 20,888 adults from the National Health and Nutrition Examination Survey (NHANES) 1999–2018. The association between CMI and CHD was assessed using weighted multivariable logistic regression. Restricted cubic splines (RCS) and threshold effect analyses explored non-linearity. A predictive model was developed and evaluated via receiver operating characteristic (ROC) analysis. RESULTS: After full adjustment, a significant positive association was observed between CMI and CHD risk (OR = 1.17, 95%CI:1.11–1.23). Participants in the highest CMI quartile had a 58% greater risk than those in the lowest (OR = 1.58, 95%CI:1.06–2.37). RCS analysis revealed a non-linear relationship (P-nonlinearity < 0.001), with a threshold identified at CMI = 1.175. Below this point, each unit increase in CMI was associated with a 133% elevation in CHD risk (OR = 2.33, 95%CI:1.83–2.97). The final predictive model, incorporating CMI and key covariates, demonstrated robust discrimination (AUC = 0.861, 95%CI:0.851–0.872). CONCLUSIONS: CMI is independently and non-linearly associated with CHD prevalence, with a heightened effect below a threshold of 1.175. This index shows promise as a practical tool for improving CHD risk stratification.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) conducted a cross-sectional in Coronary heart disease (n=20,888). Cardiometabolic index (CMI) vs. Lower CMI levels was evaluated on Prevalence of coronary heart disease (OR 1.17, 95% CI 1.11-1.23, p=<0.001). Higher cardiometabolic index is independently associated with an increased prevalence of coronary heart disease (OR 1.17 per unit increase), with a heightened effect below a threshold of 1.175.
Synapse has enriched 10 related papers. Consider them for comparative context: